Mutations in GBA2 Cause Autosomal-Recessive Cerebellar Ataxia with Spasticity
Author(s) -
Monia Hammer,
Ghada Eleuch-Fayache,
Lucía Schottlaender,
Houda Nehdi,
J. Raphael Gibbs,
Sampath K. Arepalli,
Sean Chong,
Dena Hernández,
Anna Sailer,
Guoxiang Liu,
Pramod K. Mistry,
Huaibin Cai,
Ginamarie Shrader,
Celeste Sassi,
Yosr Bouhlal,
Henry Houlden,
Fayçal Hentati,
Rim Amouri,
Andrew B. Singleton
Publication year - 2013
Publication title -
the american journal of human genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.661
H-Index - 302
eISSN - 1537-6605
pISSN - 0002-9297
DOI - 10.1016/j.ajhg.2012.12.012
Subject(s) - disease gene identification , ataxia , cerebellar ataxia , genetics , spasticity , nonsense mutation , mutation , compound heterozygosity , exome sequencing , biology , gene , medicine , missense mutation , neuroscience , physical therapy
Autosomal-recessive cerebellar ataxia (ARCA) comprises a large and heterogeneous group of neurodegenerative disorders with more than 20 different forms currently recognized, many of which are also associated with increased tone and some of which have limb spasticity. Gaucher disease is a lysosomal storage disease resulting from a defect in the enzyme acid β-glucosidase 1. β-glucosidase 2 is an enzyme with similar glucosylceramidase activity but to date has not been associated with a monogenic disorder. We studied four unrelated consanguineous families of Tunisian decent diagnosed with cerebellar ataxia of unknown origin. We performed homozygosity mapping and whole-exome sequencing in an attempt to identify the genetic origin of their disorder. We were able to identify mutations responsible for autosomal-recessive ataxia in these families within the gene encoding β-glucosidase 2, GBA2. Two nonsense mutations (c.363C>A [p.Tyr121(∗)] and c.1018C>T [p.Arg340(∗)]) and a substitution (c.2618G>A [p.Arg873His]) were identified, probably resulting in nonfunctional enzyme. This study suggests GBA2 mutations are a cause of recessive spastic ataxia and responsible for a form of glucosylceramide storage disease in humans.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom